Novo Nordisk Wins FDA Approval for Weekly Growth Hormone in Children With Turner Syndrome
The FDA approved Novo Nordisk's Sogro for weekly growth hormone treatment in children with Turner syndrome.
The FDA approved Novo Nordisk's Sogro for weekly growth hormone treatment in children with Turner syndrome.